TVRD
Tvardi Therapeutics
TVRD
TVRD
109 hedge funds and large institutions have $18.3M invested in Tvardi Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
60% less capital invested
Capital invested by funds: $45.6M → $18.3M (-$27.2M)
Holders
109
Holding in Top 10
–
Calls
$46K
Puts
$11K
Top Buyers
| 1 | +$286K | |
| 2 | +$280K | |
| 3 | +$197K | |
| 4 |
Two Sigma Investments
New York
|
+$176K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$168K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.43M | |
| 3 | -$980K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$555K |
| 5 |
PA
Pinnacle Associates
New York
|
-$473K |